WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection

SUZHOU, China, April 13, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platform, announced that WuXi Biologics (Suzhou) Co., Ltd. has successfully passed its first GMP inspection by the European Medicines Agency...

from PR Newswire: https://ift.tt/2xjK8mS